Methylone safety and treatment research for adults with PTSD
About this title
Read the official source — NCT05741710Researchers compared Methylone and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.
Understand this study
What did researchers investigate?
Researchers compared Methylone and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Denver and 15 more locationsSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 79
- Sponsor
- Transcend Therapeutics
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States, United Kingdom, Ireland
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05741710
- Official title
Show the full official title
A Pilot Study to Assess the Use of Methylone in the Treatment of PTSD IMPACT-1 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Denver, United States · Jacksonville, United States · Maitland, United States
12 more locations
- Rockville, United States
- Boston, United States
- Berlin, United States
- Oklahoma City, United States
- Murray, United States
- Dublin, Ireland
- Galway, Ireland
- Belfast, United Kingdom
- Cambridge, United Kingdom
- Glasgow, United Kingdom
- London, United Kingdom
- Oxford, United Kingdom
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Methylone and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.
Who is behind this study?
The study sponsor is Transcend Therapeutics.
Did this study involve medication?
Yes. The study involved medication, including Methylone and Placebo.
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
